Sol-Gel Technologies Ltd

XNAS:SLGL   4:00:00 PM EDT
66.79
-2.39 (-3.46%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)211.10M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.1 Million
Adjusted EPS-$2.20
See more estimates
10-Day MA$69.84
50-Day MA$77.98
200-Day MA$70.03
See more pivots

Sol-Gel Technologies Ltd Stock, XNAS:SLGL

Weizmann Science Park, 7 Golda Meir Street, Ness Ziona, Tel Aviv 74036
Israel
Phone: +972.8.931.3433
Number of Employees: 36
http://www.sol-gel.com

Description

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.